Vireo Growth (VREOF) Goodwill & Intangibles (2020 - 2026)
Vireo Growth's (VREOF) quarterly Goodwill & Intangibles came in at $202.5 million in Q1 2026, up 2531.74% year-on-year from $7.7 million in Q1 2025, and up 0.9% quarter-over-quarter from $200.7 million in Q4 2025.
Vireo Growth (VREOF) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Goodwill & Intangibles across 7 years of filings, most recently posting $202.5 million for Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $202.5 million, up 2531.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $202.5 million (up 2531.74% YoY), and the FY2025 annual result was $200.7 million, up 2440.51% from the prior year.
- Goodwill & Intangibles came in at $202.5 million for Q1 2026 at Vireo Growth, up from $200.7 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $202.5 million in Q1 2026 to a low of $7.7 million in Q1 2025.
- The 5-year median for Goodwill & Intangibles is $8.9 million (2023), against an average of $50.3 million.
- Across the five-year window, Goodwill & Intangibles fell 19.15% in 2023 and soared 2531.74% in 2026, its largest moves.
- Vireo Growth's Goodwill & Intangibles stood at $9.0 million in 2022, then dropped by 2.7% to $8.7 million in 2023, then declined by 9.39% to $7.9 million in 2024, then surged by 2440.51% to $200.7 million in 2025, then increased by 0.9% to $202.5 million in 2026.
- The last three Goodwill & Intangibles figures came in at $202.5 million (Q1 2026), $200.7 million (Q4 2025), and $180.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202.50 Mn |
| Dec 31, 2025 | 200.70 Mn |
| Sep 30, 2025 | 180.47 Mn |
| Jun 30, 2025 | 158.82 Mn |
| Mar 31, 2025 | 7.69 Mn |
| Dec 31, 2024 | 7.90 Mn |
| Sep 30, 2024 | 8.10 Mn |
| Jun 30, 2024 | 8.31 Mn |
| Mar 31, 2024 | 8.51 Mn |
| Dec 31, 2023 | 8.72 Mn |
| Sep 30, 2023 | 8.94 Mn |
| Jun 30, 2023 | 8.05 Mn |
| Mar 31, 2023 | 8.80 Mn |
| Dec 31, 2022 | 8.96 Mn |
| Sep 30, 2022 | 9.12 Mn |
| Jun 30, 2022 | 9.96 Mn |
| Mar 31, 2022 | 10.13 Mn |
| Dec 31, 2021 | 10.37 Mn |
| Sep 30, 2021 | 3.37 Mn |
| Jun 30, 2021 | 6.32 Mn |